Assessment of Relationship Between C-Reactive Protein to Albumin Ratio and Coronary Artery Disease Severity in Patients With Acute Coronary Syndrome.
Metin CagdasIbrahim RencüzoğullariSüleyman KarakoyunYavuz KarabağMahmut YesinInanç ArtaçDoğan IlişÖznur Sadioğlu ÇağdaşAysu Hayriye TezcanHalil Ibrahim TanboğaPublished in: Angiology (2017)
The association of coronary artery disease (CAD) severity with increased C-reactive protein (CRP) and decreased albumin levels has been reported. However, to our knowledge, no study has investigated the usefulness of the CRP to albumin ratio (CAR) in predicting intermediate-high SYNergy between Percutaneous Coronary Intervention with TAXus and cardiac surgery (SYNTAX) score (SS) and high SS II. Consecutive patients (n = 344) treated with percutaneous coronary intervention comprised the study population. The study population was divided into 2 groups according to SS >22 and mean SS II values, respectively. Patients with intermediate-high SS and high SS II had higher CAR than patients with low SS and SS II. History of diabetes mellitus, decreased albumin, lower left ventricular ejection fraction, and elevated CAR (odds ratio [OR]: 1.020; 95% confidence interval [CI], 1.009-1.031; P < .001) were independent predictors of high SS. The presence of hypertension, decreased hemoglobin and albumin levels, and increased CAR (OR: 1.014; 95% CI, 1.004-1.023; P < .001) were independent predictors of SS II. In receiver operating characteristic curve comparison, CAR was superior to CRP and albumin in prediction of intermediate-high SS, but only CRP in prediction of high SS II. The CAR calculated from the admission blood samples could be a useful parameter for predicting CAD severity using SS and SS II.
Keyphrases
- coronary artery disease
- percutaneous coronary intervention
- ejection fraction
- cardiac surgery
- left ventricular
- aortic stenosis
- acute myocardial infarction
- blood pressure
- heart failure
- emergency department
- end stage renal disease
- coronary artery bypass grafting
- chronic kidney disease
- st segment elevation myocardial infarction
- healthcare
- antiplatelet therapy
- cardiovascular disease
- newly diagnosed
- acute kidney injury
- st elevation myocardial infarction
- weight loss
- mass spectrometry
- skeletal muscle
- single molecule
- glycemic control